Posts in LSE:DTG

A ready-made buy and hold ISA portfolio

A ready-made buy and hold ISA portfolio

Companies analyst Richard Beddard picks 10 shares to buy and hold, not just for the next tax year, but indefinitely.

2 under-the-radar growth stocks I’d consider buying before the ISA deadline

Buying stock in companies that rarely make the headlines can often be a sound strategy, particularly if the shares are held in an ISA. Not only is there the possibility of the shares re-rating as the herd arrives, any resultant capital gains are automatically protected from the taxman.

With time running out to take advantage of your £20,000 allowance (the current tax year ends on 5 April), here are a couple of stocks that appear to still be flying under many investors' radars.

Weaker miners drag on FTSE

A lack of direction from the US on Monday and a decline in miners on the back of weaker metal prices hit the FTSE 100, down 0.6% at 7,247.

Fresnillo (FRES) declined 2.8% to £13.61 and Randgold Resources (RRS) slipped 2.6% to £61.40.

Antofagasta (ANTO) and Anglo American (AAL) also suffered falls of up to 1.8% each.

Outside of miners, a big faller was consumer products colossus Reckitt Benckiser (RB.).

The Nurofen and Clearasil owner revealed like-for-like sales were flat in 2017 and its margins missed consensus, causing the shares to fall 7.5% to £60.75.

One FTSE 100 stock and one growth star I’d always buy on the dips

When shares in a company you like fall sharply, it's worth asking why. Has something fundamental gone wrong with the business, or is it just a minor bump in the road?

Selling stocks because of short-term weakness can be a costly mistake. In these situations, I often consider using the weaker price to top up my holding instead.

I believe we're likely to face more market volatility this year, so today I'm looking at two companies I'd be happy to buy on the dips.

FTSE falls flat on weaker miners

A strong performance in Asia this morning failed to fuel the FTSE 100, with weakness in miners holding back any positive momentum.

Gold miner Randgold Resources (RRS) retreated 1.3% to £62.20 and Fresnillo (FRES) nudged 1% lower to £13.85.

Another key faller was consumer products colossus Reckitt Benckiser (RB.). The Nurofen and Clearasil owner revealed like-for-like sales were flat in 2017 and its margins missed consensus, causing the shares to fall 5.1% to £62.31.

UK stocks open flat as investors await key economic data

UK stocks opened flat on Monday as investors took pause after the previous week's strong gains and awaited the release this week of key economic data.

At 0859, the benchmark FTSE 100 index was up 1.44 points at 7,296.14.

Consumer goods distributor Reckitt Benckiser fell 2.9% after the market looked past some positive revenue guidance and focused on margin compression at its recently-acquired infant formula business.

AstraZeneca, meanwhile, said US regulators had approved a new treatment for lung cancer.

Dart Group sees pretax profit 'materially' ahead of market expectations

Dart Group said it expects profit before tax to be 'materially' ahead of current market expectations in fiscal 2018 amid continued success of its leisure travel business and a more normalised pricing environment.

The group said forward bookings in its leisure travel business for summer 2018 were 'presently satisfactory,' amid 'encouraging' performance from its two new operating bases at London Stansted and Birmingham airports.

'It is still early in the leisure travel booking cycle and we remain cautious on pricing.

Seven secrets of modern scuttlebutt

Seven secrets of modern scuttlebutt

A way of gathering information from unconventional sources popularised over half a century ago, can help us discover, buy, and hold good companies, argues Richard Beddard.

15 stocks in the 'buy zone'

15 stocks in the 'buy zone'

After rejigging the algorithm and reassessing every share ranked by his Decision Engine stock screener, companies analyst Richard Beddard has a lot to report on.

Director Deals - Dart Group PLC (DTG)

Stephen Heapy, Executive Director, sold post-exercise 12,425 shares in the company on the 7th December 2017 at a price of 689.12p. The Director now holds 185,211 shares.

NOTE: Sold to cover tax liabilities etc.

Director deals data provided by